The microbiological epidemiology of infections in peritoneal dialysis over a 45-year period in the Peritoneal Dialysis Registry in France (RDPLF)

Authors

  • Florian Baquer Laboratoire de Bactériologie, CHU de Strasbourg, 67000 Strasbourg https://orcid.org/0009-0009-9978-9921
  • Françoise Heibel Service de néphrologie, CHU de Strasbourg, 67000 Strasbourg
  • Larbi Bencheikh Service de néphrologie, CHU de Strasbourg, 67000 Strasbourg https://orcid.org/0000-0001-5269-7792
  • Antoine Grillon Laboratoire de Bactériologie, CHU de Strasbourg, 67000 Strasbourg

DOI:

https://doi.org/10.25796/bdd.v8i3.87082

Keywords:

dialyse péritonéale, péritonite, microbiologie, infection

Abstract

Infectious peritonitis remains a frequent complication of peritoneal dialysis. Over the years, numerous technical advancements have been introduced, aimed at both reducing the incidence of these infections and enhancing their microbiological characterization. In this study, we analyzed 26,235 peritonitis episodes recorded in the French-Language Peritoneal Dialysis Registry (RDPLF) database to describe the evolution of infectious epidemiology from the 1980s to the present day.
Our findings reveal a marked decrease in the proportion of staphylococcal infections between 1978 and 2010. Conversely, infections caused by Enterobacteriaceae, enterococci, and streptococci have progressively increased over the same period. The modality of peritoneal dialysis appears to be associated with specific bacterial profiles: infections involving skin flora are more prevalent in continuous ambulatory peritoneal dialysis, whereas those of environmental or mixed (oral/gastrointestinal) origin are more frequently observed with automated peritoneal dialysis.
The advent of advanced diagnostic techniques, particularly molecular biology methods, has significantly improved the microbiological documentation of peritonitis, especially for organisms that are non-cultivable or difficult to culture by conventional laboratory methods.
In summary, this study presents the microbiological trends observed in peritoneal dialysis-associated peritonitis in France from the 1980s to the present, based on data from over 20,000 patients included in the RDPLF database, and highlights the impact of evolving technological approaches on the detection and understanding of these infections.

References

1. Couchoud C, Raffray M, Lassalle M, Duisenbekov Z, Moranne O, Erbault M, et al. Prevalence of chronic kidney disease in France: methodological considerations and pitfalls with the use of health claims databases. Clin Kidney J 2024;17:117. doi:10.1093/ckj/sfae117.

2. Issad B, Galland R, Merle V, Lobbedez T, Lassalle M. Prevalence of CKD and share of different treatment modalities. Nephrol Ther 2022;18:18/5S-e15-18/5S-e20. doi:10.1016/S1769-7255(22)00563-6.

3. Manns BJ, Taub K, Vanderstraeten C, Jones H, Mills C, Visser M, et al. The impact of education on chronic kidney disease patients’ plans to initiate dialysis with self-care dialysis: a randomized trial. Kidney Int 2005;68:1777-83. doi:10.1111/j.1523-1755.2005.00594.x.

4. Li PK-T, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int 2022;42:110-53. doi:10.1177/08968608221080586.

5. Verger C, Veniez G, Padernoz M-C, Fabre E. Home dialysis in French speaking countries in 2020 (RDPLF database). Bull Dial Domic 2021;4:55-70. doi:10.25796/bdd.v4i1.61543.

6. Yoon SH, Choi NW, Yun SR. Detecting bacterial growth in continuous ambulatory peritoneal dialysis effluent using two culture methods. Korean J Intern Med 2010;25:82-5. doi:10.3904/kjim.2010.25.1.82.

7. Pindi G, Kawle V, Sunkara RR, Darbha MS, Garikaparthi S. Continuous ambulatory peritoneal dialysis peritonitis: microbiology and outcomes. Indian J Med Microbiol 2020;38:72-7. doi:10.4103/ijmm.IJMM_20_251.

8. Yin S, Tang M, Rao Z, Chen X, Zhang M, Liu L, et al. Risk factors and pathogen spectrum in continuous ambulatory peritoneal dialysis-associated peritonitis: a single center retrospective study. Med Sci Monit 2022;28:e937112. doi:10.12659/MSM.937112.

9. Mertz D, Frei R, Periat N, Zimmerli M, Battegay M, Flückiger U, et al. Exclusive Staphylococcus aureus throat carriage: at-risk populations. Arch Intern Med 2009;169:172-8. doi:10.1001/archinternmed.2008.536.

10. Wertheim HFL, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005;5:751-62. doi:10.1016/S1473-3099(05)70295-4.

11. D’Souza AL. Ageing and the gut. Postgrad Med J 2007;83:44-53. doi:10.1136/pgmj.2006.049361.

12. Huo Z, Zhuo Q, Zhong S, Wang F, Xie C, Gong N, et al. Hypokalemia duration in the first year associated with subsequent peritoneal dialysis-associated peritonitis: a multicenter retrospective cohort study. J Clin Med 2022;11. doi:10.3390/jcm11247518.

13. Chuang Y-W, Shu K-H, Yu T-M, Cheng C-H, Chen C-H. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant 2009;24:1603-8. doi:10.1093/ndt/gfn709.

14. Maeda S, Yamaguchi M, Maeda K, Kobayashi N, Izumi N, Nagai M, et al. Proton pump inhibitor use increases the risk of peritonitis in peritoneal dialysis patients. PLoS One 2019;14:e0224859. doi:10.1371/journal.pone.0224859.

15. Lepelletier D, Saliou P, Lefebvre A, Lucet J-C, Grandbastien B, Bruyère F, et al. “Preoperative risk management: strategy for Staphylococcus aureus preoperative decolonization” (2013 update). French Society of Hospital Hygiene. Med Mal Infect 2014;44:261-7. doi:10.1016/j.medmal.2014.04.003.

16. Klaus G. Prevention and treatment of peritoneal dialysis-associated peritonitis in pediatric patients. Perit Dial Int 2005;25 Suppl 3:S117-9.

17. Verger C, Veniez G, Dratwa M. Variability of aseptic peritonitis rates in the RDPLF. Bull Dial Domic 2018;1:9-13. doi:10.25796/bdd.v1i1.30.

18. P, Xie C, Wu C, Yu C, Chen Y, Liang Z, et al. The application of metagenomic next-generation sequencing for detection of pathogens from dialysis effluent in peritoneal dialysis-associated peritonitis. Perit Dial Int 2022;42:585-90. doi:10.1177/08968608221117315.

19. Burnham P, Chen F, Cheng AP, Srivatana V, Zhang LT, Edusei E, et al. Peritoneal effluent cell-free DNA sequencing in peritoneal dialysis patients with and without peritonitis. Kidney Med 2022;4:100383. doi:10.1016/j.xkme.2021.08.017.

Submitted

2025-06-16

Accepted

2025-07-08

Published

2025-09-14

How to Cite

1.
Baquer F, Heibel F, Bencheikh L, Grillon A. The microbiological epidemiology of infections in peritoneal dialysis over a 45-year period in the Peritoneal Dialysis Registry in France (RDPLF) . Bull Dial Domic [Internet]. 2025 Sep. 14 [cited 2025 Sep. 14];8(3):229-40. Available from: https://www.bdd.rdplf.org/index.php/bdd/article/view/87082